C07K 9/005
Containing within the molecule the substructure [image cpc-sch-c07k-1009.gif] with m, n >
Official title: {containing within the molecule the substructure [IMAGE cpc-sch-C07K-1009.gif] with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides}
C07K9/005 (Containing within the molecule the substructure [image cpc-sch-c07k-1009.gif] with m, n >) appears on 154 US grants and 54 published applications in this corpus.
Search patents in C07K- Granted patents
- 154
- Published applications
- 54
- Assignees
- 90
- Inventors
- 302
- Latest grant
- 5 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 10 | 0 |
| 1983 | 15 | 0 |
| 1984 | 8 | 0 |
| 1985 | 6 | 0 |
| 1986 | 3 | 0 |
| 1987 | 9 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 4 |
| 2004 | 0 | 3 |
| 2005 | 1 | 3 |
| 2006 | 4 | 8 |
| 2007 | 3 | 3 |
| 2008 | 3 | 1 |
| 2009 | 2 | 7 |
| 2010 | 2 | 3 |
| 2011 | 3 | 3 |
| 2012 | 3 | 2 |
| 2013 | 1 | 1 |
| 2014 | 2 | 3 |
| 2015 | 7 | 1 |
| 2016 | 3 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 3 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 2 | 0 |
| 2022 | 2 | 1 |
| 2023 | 0 | 2 |
| 2024 | 2 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Muramyl peptide derivatives5 Nov 2024US 12,134,664 B2Bharat Biotech International Limited
- Immunogenic composition29 Oct 2024US 12,128,096 B2Glaxosmithkline Biologicals SA
- Immunogenic composition5 Jul 2022US 11,376,314 B2Glaxosmithkline Biologicals SA
- Skin treatment devices and methods with pre-stressed configurations15 Feb 2022US 11,246,763 B2The Board of Trustees of the Leland Stanford Junior University
- Synthetic N-acetyl-muramic acid derivatives and uses thereof27 Apr 2021US 10,988,508 B2University of Delaware
- Novel therapeutic methods of using peptidoglycan muropeptides to promote atp synthase activity and mitochondrial homeostasis and development25 Sep 2025US 2025/0295729 A1The Regents of the University of Colorado, a body corporate
- Method for producing glycopeptide1 Aug 2024US 2024/0254165 A1KH Neochem Co., Ltd.
- Compositions for treating epithelial barrier function disorders17 Aug 2023US 2023/0257423 A1
- Immunogenic composition2 Mar 2023US 2023/0060184 A1Glaxosmithkline Biologicals SA
- Muramyl Peptide Derivatives24 Feb 2022US 2022/0056080 A1Bharat Biotech International Limited
Most cited
By later US patents
- PNA-DNA-PNA chimeric macromolecules416US 5,700,922 AIsis Pharmaceuticals, Inc. · 1997
- Devices and bandages for the treatment or prevention of scars and/or keloids and methods and kits therefor67US 7,683,234 B2The Board of Trustees of the Leland Stanford Junior University · 2010
- Novel immunological adjuvant compounds and methods of preparation thereof57US 4,082,736 ASyntex (U.S.A.) Inc. · 1978
- Conjugates useful in the treatment of prostate cancer53US 5,998,362 AMerck & Co., Inc. · 1999
- Novel immunological adjuvant compounds and methods of preparation thereof52US 4,082,735 ASyntex (U.S.A.) Inc. · 1978